Gracell Biotechnologies Inc (GRCL) Cours

Form 15-12G - Securities registration termination [Section 12(g)]

Form EFFECT - Notice of Effectiveness

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form POS AM - Post-Effective amendments for registration statement

Form POS AM - Post-Effective amendments for registration statement

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Gracell Biotechnologies Acquisition Completed

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, Nasdaq: GRCL), a global clinical-stage...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement

SAN DIEGO and SUZHOU, China and SHANGHAI, China, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (“Gracell” or the “Company”, NASDAQ: GRCL), a global clinical-stage...